Founded by DeepMind alumnus, Latent Labs launches with $50M to make biology programmable
A new startup from one of the key scientists at Google DeepMind exits stealth today with $50 million in funding.
OKYO Pharma Announces OK-101 Officially Assigned USAN : Urcosimod
The USAN designation reflects Okyo Pharma’s commitment to developing new therapies for unmet medical needs in ophthalmology. The suffix “-mod” in urcosimod denotes its classification as a modulator of ...